Latest Earnings Results: Q3 '26
Estimated EPS
$2.52
Reported EPS
$2.59
Surprise
+2.68%
Estimated Rev
$25.38B
Reported Rev
$25.4B
Surprise
+0.06%
Johnson & Johnson raised 2026 estimated reported sales guidance to $101B$101.4B, with midpoint $101.2B, and adjusted EPS guidance to $11.05$11.15, midpoint $11.10, or 7.4% and 2.9% at midpoint.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $2.90 | -- | -- | N/A |
Q3 '26 | $2.52 | $2.59 | 2.68% | BEAT |
Q2 '26 | $2.85 | $2.90 | 1.59% | BEAT |
Q1 '26 | $2.68 | $2.70 | 0.85% | BEAT |
Q4 '25 | $2.46 | $2.46 | -0.12% | MISSED |